Stock listing

FATE Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: FATE · BOATS · USD · US

FATE:BOATS is the public listing for Fate Therapeutics, Inc., a biotechnology company based in the United States that specializes in developing innovative cell therapies for cancer and immune disorders. The company is committed to advancing its proprietary technology platform to enhance patient outcomes. With a market capitalization of around $324 million, Fate Therapeutics continues to make strides in the biotechnology sector, focusing on its research and development efforts to address critical medical needs. Recent news and filings reflect the company's ongoing initiatives and progress in the field.